F Fuzkk Atlas of the EU, Switzerland, the United Kingdom and Israel
#129FUZKK selection 101–300

Adocia

France · European Union

Peptides and complex injectablesFinished dosage forms and small molecules

Manufacturing profile

Country
France
Regulatory region
European Union
ISO
FRA

Selection basis

The company is placed in positions 101–300 as a manufacturer, biotechnology company, generics player or CDMO with practical relevance to the FUZKK utility catalog.

The Top 300 is a FUZKK atlas priority rather than a single official revenue table. The mapping does not claim actual use of FUZKK, a specific installed equipment model or a product not confirmed by the public company profile.

Representative manufacturing and QC chain

  1. 1Peptide synthesis or recombinant upstream
  2. 2Chromatography and UF/DF
  3. 3HPLC/LC-MS and CE peptide mapping
  4. 4Sterile filtration and cartridge/vial filling
  5. 5Particles, sterility, endotoxin and cold-chain release
  6. 6Raw-material receipt and identification
  7. 7Dispensing, blending and granulation
  8. 8Tableting, encapsulation or solution preparation
  9. 9Packaging and labelling

Relevant FUZKK packages

France: national essential medicines QC packagePeptides, GLP-1 and Obesity QC SuiteGlobal API & Biosimilars QC SuiteLumex QC SuiteLabEx QC Suite

Product/API utilities

Insulin Analog Impurity CheckerHuman Insulin Quality CheckerGLP1 Injectable Release CheckerAssay & Impurities Result Reviewer

Lumex — instrumental QC

CE Peptide Map ValidatorCE Peptide Map FingerprintInsulinHumanHPLCChecker

LabEx — laboratory QC

LC-MS Confirmation Quality CheckerBacterial Endotoxins LAL Quality CheckerSterility Test Membrane Filtration Quality CheckerAssay & Impurity HPLC Quality CheckerResidual Solvents GC Quality CheckerWater Content KF Quality CheckerElemental Impurities ICP Quality CheckerContent Uniformity Quality CheckerDissolution Apparatus 1 & 2 Quality CheckerStability Condition Monitoring Quality Checker

Medical Devices — equipment and software lifecycle

Process Validation CheckerData Integrity Security CheckerSupplier Evaluation CheckerCalibration Status CheckerChange Control Impact CheckerRequirement Traceability Checker

Suggested first pilot

  1. Confirm one real product, method or recurring QC review.
  2. Record the instrument, export format and current specification.
  3. Select 3–7 utilities from the map above.
  4. Run a PASS/FAIL sample and agree the expected output.
  5. After user validation, expand to other products and sites.

Mapping boundary

The Top 300 is a FUZKK atlas priority rather than a single official revenue table. The mapping does not claim actual use of FUZKK, a specific installed equipment model or a product not confirmed by the public company profile.

Methodology